New Deletions in the Hermansky-Pudlak Syndrome Type 5 Gene in a Japanese Patient

被引:1
|
作者
Kato, Shinya [1 ]
Aoe, Tsugumi [2 ]
Hamamoto, Akie [2 ]
Takemori, Hiroshi [3 ]
Nishikubo, Toshiya [4 ]
机构
[1] Gifu Univ, Dept Life Sci & Chem, Grad Sch Nat Sci & Technol, Yanagido 1-1, Gifu 5011193, Japan
[2] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Yanagido 1-1, Gifu 5011193, Japan
[3] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Yanagido 1-1, Gifu 5011193, Japan
[4] Nara Med Univ, Div Neonatal Intens Care, Ctr Maternal Fetal Med, 840 Shijo, Kashihara, Nara 6348522, Japan
关键词
Hermansky-Pudlak syndrome type 5; oculocutaneous albinism; platelet aggregation; variant;
D O I
10.3390/reports2020015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Hermansky-Pudlak syndrome (HPS) is a rare disease characterized by oculocutaneous albinism and prolonged bleeding. HPS is caused by alterations in HPS1-10 and their related genes, comprising the biogenesis of lysosome-related organelles complex 1-3 and adapter protein 3. Here, we report a Japanese patient with HPS associated with mild hypopigmentation, nystagmus, and impaired visual acuity. Sequencing analyses of the mRNA of this patient revealed new deletions (Delta GA and Delta G) in the HPS5 gene. This was the first case of HPS5 gene deficiency in Japan, and the two above-mentioned deletions have not yet been reported among patients with HPS5.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Identification of two novel mutations in a Japanese patient with Hermansky-Pudlak syndrome type 5
    Saito, Toru
    Okamura, Ken
    Funasaka, Yoko
    Abe, Yuko
    Suzuki, Tamio
    JOURNAL OF DERMATOLOGY, 2020, 47 (11): : E392 - E393
  • [2] Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
    Stephen, Joshi
    Yokoyama, Tadafumi
    Tolman, Nathanial J.
    O'Brien, Kevin J.
    Nicoli, Elena-Raluca
    Brooks, Brian P.
    Huryn, Laryssa
    Titus, Steven A.
    Adams, David R.
    Chen, Dong
    Gahl, William A.
    Gochuico, Bernadette R.
    Malicdan, May Christine V.
    PLOS ONE, 2017, 12 (03):
  • [3] A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5
    Korswagen, Lindy-Anne
    Huizing, Marjan
    Simsek, Suat
    Janssen, Jeroen J. W. M.
    Zweegman, Sonja
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (04) : 356 - 360
  • [4] Hermansky-Pudlak syndrome in a pregnant patient
    Poddar, RK
    Coley, S
    Pavord, S
    BRITISH JOURNAL OF ANAESTHESIA, 2004, 93 (05) : 740 - 742
  • [5] NOT YOUR USUAL CASE OF HERMANSKY-PUDLAK SYNDROME: A CASE PRESENTATION OF SARCOIDOSIS IN A HERMANSKY-PUDLAK SYNDROME TYPE 1 PATIENT
    Gorbea, Kyrsha
    Sanchez, Milaris
    Roman-Carlo, Rosa I.
    Egozcue-Dionisi, Monica M.
    Vazquez, Danessa
    Caro, Alejandra Rivera
    CHEST, 2024, 166 (04) : 3494A - 3494A
  • [6] Milder ocular findings in Hermansky-Pudlak syndrome type 3 compared with Hermansky-Pudlak syndrome type 1
    Tsilou, ET
    Rubin, BI
    Reed, GF
    McCain, L
    Huizing, M
    White, J
    Kaiser-Kupfer, MI
    Gahl, W
    OPHTHALMOLOGY, 2004, 111 (08) : 1599 - 1603
  • [7] Hermansky-Pudlak syndrome
    Ambur, Austin B.
    Nyckowski, Timothy A.
    JOURNAL OF OSTEOPATHIC MEDICINE, 2022, 122 (11): : 601 - 602
  • [8] Hermansky-Pudlak syndrome
    Atili, A.
    Luebke, J.
    Shoukier, M.
    Schittkowski, M. P.
    OPHTHALMOLOGE, 2013, 110 (02): : 160 - 163
  • [9] HERMANSKY-PUDLAK SYNDROME
    SCHALLREUTER, KU
    HAUTARZT, 1989, 40 (03): : 130 - 133
  • [10] Hermansky-Pudlak syndrome
    Dimson, O
    Drolet, BA
    Esterly, NB
    PEDIATRIC DERMATOLOGY, 1999, 16 (06) : 475 - 477